MS affects more than 450,000 people in the United State and more than 2.3 million worldwide. Despite being first described over 150 years ago, there is still no known cause or cure.
Thanks to research, great advances have been made in the past twenty years in uncovering the etiology of the disease and the development of new treatments, such as the advent of disease-modifying drugs. For many with MS, progression can now be slowed. But there is still too much that is unknown.
Until recently, funding for MS research has been primarily through government sources and, in the case of new drug discovery, through pharmaceutical companies. Other important funding comes from organizations such as the National Multiple Sclerosis Society.
ARMS was formed to encourage researchers to explore promising and possibly nontraditional avenues of research to identify more ways people with MS can improve their quality of life. We feel this is a very promising time of discovery in MS and want to be a force in stimulating research.